Monitoring des metastasierten Nierenzellkarzinoms – Standards und Herausforderungen

Publisher： Karger

E-ISSN： 2296-5262|33|1|15-17

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.33, Iss.1, 2010-01, pp. : 15-17

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Aktuelle Aspekte der Second-line- und Sequenztherapie des metastasierten Nierenzellkarzinoms

By  

Oncology Research and Treatment, Vol. 33, Iss. 1, 2010-01 ,pp. : 10-11

Karger

Access to resources Recommend Favorite

Erstlinientherapie des metastasierten Nierenzellkarzinoms (mRCC) – Update 2009

By  

Oncology Research and Treatment, Vol. 33, Iss. 1, 2010-01 ,pp. : 5-9

Karger

Access to resources Recommend Favorite

Die urologische Therapie des Nierenzellkarzinoms

By Ferber Wolfgang  

Wiener Medizinische Wochenschrift, Vol. 158, Iss. 11-12, 2008-06 ,pp. : 307-311

Springer Publishing Company

Access to resources Recommend Favorite

Systemtherapie des metastasierten malignen Melanoms

By  

JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, Vol. 13, Iss. 12, 2015-12 ,pp. : 1223-1238

John Wiley & Sons Inc

Access to resources Recommend Favorite

Ausblick: Therapie des Nierenzellkarzinoms von morgen

By  

Oncology Research and Treatment, Vol. 33, Iss. 1, 2010-01 ,pp. : 18-20

Karger

Access to resources Recommend Favorite